RWCS

 

RWCS
A

RWCS 2021 Highlights on Biologics/tsDMARDs: What Are the Commonly Considered Potential Safety Issues? What Is the Lymphoma Incidence in RA & Risk for VTE?

By RWCS FEATURING Arthur Kavanaugh, John J. Cush
By RWCS FEATURING Arthur Kavanaugh, John J. Cush
209 views
April 9, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

25:06
Genentech Rheumatology

Are your patients with moderate to severe Rheumatoid Arthritis (RA) …

Feat. O. Troum, A. Wells, A. Broadwell, G. Wright

Featured Video

28:46
Boehringer Ingelheim

Systemic Sclerosis-Associated Interstitial Lung Disease: A Patient&#…

Feat. E. Volkmann
RWCS 2021 Virtual Meeting
08:39

RWCS 2021 Review on Early RA: How Often Does Subclinical Synovitis R…

RWCS

A. Kavanaugh, J. Cush

75 views
25:43

RWCS 2021 Highlights on RA Management: Which Medications Are Current…

RWCS

A. Kavanaugh, J. Cush

171 views
08:19

RWCS 2021 Highlights on Biologics/tsDMARDs: What Are the Commonly Co…

RWCS

A. Kavanaugh, J. Cush

209 views
07:38

RWCS 2021 Virtual Meeting: New Developments in RA Q&A

RWCS

A. Kavanaugh, J. Cush

76 views